Home » Topics » BioWorld Science

BioWorld Science
RSS

Arix, Evotec and Fred Hutchinson establish academic bridge collaboration

May 31, 2018

FDA grants priority review to Fycompa pediatric sNDA

May 31, 2018

GlycoMimetics enters agreement with NCI for pivotal study of uproleselan in AML

May 31, 2018

FDA approves Xeljanz for moderate to severely active ulcerative colitis

May 31, 2018

GSK, Cloud Pharmaceuticals form drug discovery collaboration

May 31, 2018

Zai Lab and Crescendo enter licensing agreement for antibody VH domain therapeutic

May 31, 2018

Researchers develop early-metastatic RCC model in chickens

May 31, 2018

U7-snRNA therapy targeting the DUX4 gene developed for facioscapulohumeral muscular dystrophy

May 31, 2018

Japanese researchers divulge RDH10 inhibitors

May 31, 2018

Researchers from U.S. patent 5-HT1F receptor agonists

May 31, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...